Skip to content

Vor Biopharma VOR Total Assets

Total Assets at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$200.89B+3.7%
Amgen logo
AmgenAMGN
$92.5B+3.5%
Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
$26.48B+15.8%
Dianthus Therapeutics logo
Dianthus TherapeuticsDNTH
$1.25B+258%
Cullinan Therapeutics, Inc. logo
Cullinan Therapeutics, Inc.CGEM
$402.98M-30.5%
Design Therapeutics, Inc. logo
Design Therapeutics, Inc.DSGN
$230.44M-3.0%

Other financials

Income statement

See full
Operating income-$35.2M-5.6%
Net income-$219.6M-576%
EPS (diluted)-$5.11+1.9%

Balance sheet

See full
Cash & equivalents$169.9M+239%
Total debt$2.9M-90.5%
Total equity-$150.4M-328%

Cash flow

See full
Operating cash flow-$38.2M-23.1%
CapEx$48.0K-79.2%
Free cash flow-$38.3M-22.4%

Valuation

See full
Market cap$784.61M+2,513%
Enterprise value$617.68M+5,639%

Returns & leverage

See full
Return on equity-125.4%+671pp
Debt / equity0.5×+0.2×
Current ratio31.1×+27.3×

Where this comes from

Reported directly by Vor Biopharma in its filing.

Tagged under the XBRL concept us-gaap:Assets.

The official record: Vor Biopharma’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vor Biopharma's total assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Vor Biopharma's total assets?
Vor Biopharma (VOR) reported total assets of $506.75M in Q1 2026.
How has Vor Biopharma's total assets changed year-over-year?
Vor Biopharma's total assets increased by 363.6% year-over-year, from $109.31M to $506.75M.
What is the long-term trend for Vor Biopharma's total assets?
Over 5 years (2020 to 2025), Vor Biopharma's total assets has grown at a 43.6% compound annual growth rate (CAGR), from $75.91M to $464.13M.
What does total assets mean?
The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.